<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 31 Aug 2026 09:02:25 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Health Canada approves Sunshine Biopharma's generic Atenolol tablets</title>
   <link>http://www.streetinsider.com/Corporate+News/Health+Canada+approves+Sunshine+Biopharma%27s+generic+Atenolol+tablets/27001910.html</link>
   <description>&lt;p&gt;Sunshine Biopharma Inc. (NASDAQ: SBFM) announced that Health Canada has approved its Atenolol tablets in 25mg, 50mg, and 100mg doses for the Canadian market, according to a company press release.&lt;/p&gt;&lt;p&gt;Atenolol is a beta-blocker and the generic equivalent of the brand-name drug Tenormin. It is indicated for managing hypertension, treating angina pectoris, and improving survival rates following a heart attack.&lt;/p&gt;&lt;p&gt;The company said it anticipates the product will be ready to ship to Canadian pharmacies by the end of 2026. Distribution will be handled through its wholly owned Canadian subsidiary, Nora Pharma Inc.&lt;/p&gt;&lt;p&gt;&quot;With the approval of Atenolol oral tablets, Sunshine Biopharma continues</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Health+Canada+approves+Sunshine+Biopharma%27s+generic+Atenolol+tablets/27001910.html</guid>
   <pubDate>Mon, 31 Aug 2026 09:02:25 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Health Canada approves Sunshine Biopharma's generic Atenolol tablets</title>
   <link>http://www.streetinsider.com/FDA/Health+Canada+approves+Sunshine+Biopharma%27s+generic+Atenolol+tablets/27001910.html</link>
   <description>&lt;p&gt;Sunshine Biopharma Inc. (NASDAQ: SBFM) announced that Health Canada has approved its Atenolol tablets in 25mg, 50mg, and 100mg doses for the Canadian market, according to a company press release.&lt;/p&gt;&lt;p&gt;Atenolol is a beta-blocker and the generic equivalent of the brand-name drug Tenormin. It is indicated for managing hypertension, treating angina pectoris, and improving survival rates following a heart attack.&lt;/p&gt;&lt;p&gt;The company said it anticipates the product will be ready to ship to Canadian pharmacies by the end of 2026. Distribution will be handled through its wholly owned Canadian subsidiary, Nora Pharma Inc.&lt;/p&gt;&lt;p&gt;&quot;With the approval of Atenolol oral tablets, Sunshine Biopharma continues</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Health+Canada+approves+Sunshine+Biopharma%27s+generic+Atenolol+tablets/27001910.html</guid>
   <pubDate>Mon, 31 Aug 2026 09:02:25 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions</title>
   <link>http://www.streetinsider.com/Press+Releases/Health+Canada+Approves+Sunshine+Biopharma%27s+Atenolol+for+Treating+and+Managing+Cardiovascular+Conditions/27001885.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;FORT LAUDERDALE, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / August 31, 2026 / &lt;/strong&gt;Sunshine Biopharma Inc. (NASDAQ:SBFM) (the &quot;Company&quot;), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its Atenolol tablets of 25mg, 50mg and 100mg for the Canadian market. Atenolol is the generic equivalent of the brand name, Tenormin®.&lt;/p&gt;&lt;p&gt;Atenolol belongs to a class of drugs known as beta-blockers. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, on the heart and blood vessels. This effect lowers the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Health+Canada+Approves+Sunshine+Biopharma%27s+Atenolol+for+Treating+and+Managing+Cardiovascular+Conditions/27001885.html</guid>
   <pubDate>Mon, 31 Aug 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/Health+Canada+Approves+Sunshine+Biopharma%27s+Atenolol+for+Treating+and+Managing+Cardiovascular+Conditions/27001885.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;FORT LAUDERDALE, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / August 31, 2026 / &lt;/strong&gt;Sunshine Biopharma Inc. (NASDAQ:SBFM) (the &quot;Company&quot;), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its Atenolol tablets of 25mg, 50mg and 100mg for the Canadian market. Atenolol is the generic equivalent of the brand name, Tenormin®.&lt;/p&gt;&lt;p&gt;Atenolol belongs to a class of drugs known as beta-blockers. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, on the heart and blood vessels. This effect lowers the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/Health+Canada+Approves+Sunshine+Biopharma%27s+Atenolol+for+Treating+and+Managing+Cardiovascular+Conditions/27001885.html</guid>
   <pubDate>Mon, 31 Aug 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Form  S-1        Sunshine Biopharma Inc.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Sunshine+Biopharma+Inc.++++++++++++++/26998123.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998123.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Sunshine+Biopharma+Inc.++++++++++++++/26998123.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.06705866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Form  S-1        Sunshine Biopharma Inc.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Sunshine+Biopharma+Inc.++++++++++++++/26998123.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998123.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Sunshine+Biopharma+Inc.++++++++++++++/26998123.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.06705866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Form  8-K        Sunshine Biopharma Inc.   For: Aug 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sunshine+Biopharma+Inc.+++For%3A+Aug+25/26997847.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26997847.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sunshine+Biopharma+Inc.+++For%3A+Aug+25/26997847.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.06705866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>Form  8-K        Sunshine Biopharma Inc.   For: Aug 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sunshine+Biopharma+Inc.+++For%3A+Aug+25/26997847.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26997847.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sunshine+Biopharma+Inc.+++For%3A+Aug+25/26997847.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.06705866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
  <item>
   <title>A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</link>
   <description>&lt;p&gt;&lt;strong&gt;A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  26, 2026  (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks like and help it go after those cancer cells. That matters in lung cancer because every tumor can be different, and some eventually learn</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Multibillion-Dollar+mRNA+Cancer+Market+Is+Taking+Shape+Targeting+Lung+Cancer%E2%80%99s+Biggest+Opportunity/26978285.html</guid>
   <pubDate>Wed, 26 Aug 2026 09:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BNTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBFM</category>
   	  </item>
 </channel>
</rss>
